Reddit Posts
Does anyone know why AstraZeneca's (AZN on Nasdaq) retained earnings are negative?
☠️🩸AstraZeneca (NASDAQ: AZN) Phase 3 Drug for Lung Cancer Killed People. Here is why the Stock WILL Bleed to Death This Week 🩸☠️.
Mirati | Investors are to Fight Losses from $MRTX downfall.
Ionis, AstraZeneca report positive outcomes from eplontersen trial (NASDAQ:AZN)
2023-03-07 Wrinkle-brain Plays (Mathematically derived options plays)
Daily U.S. Stock Market News Ticker (Monday, March 6)
$AIM Try to name another bio stock in trials with $BMY $MRK $AZN and PFE.
"$CEMI - CHEMBIO DIAGNOSTICS - BUY UNDER .50"
2022-11-08 Wrinkle-brain Plays (Mathematically derived options plays)
AstraZeneca's (AZN) Evusheld Increases Risk Of Developing Covid 19 When Exposed To Variants Not Neutralized By Evusheld - FDA
AstraZeneca's (AZN) Evusheld Increares Risk Of Developing Covid 19 When Exposed To Variants Not Neutralized By Evusheld - FDA
"$CEMI - BUY UNDER .50 BEFORE THE NEXT P.R. TRIPLES THE SHARE PRICE"
"$CEMI - Chembio Diagnostics - Buy Under .50"
$TCRT CURED CANCER. Deadass Serious. Warning: Actual Due Diligence Inside.
"$CEMI RECEIVES $3.25M C.D.C. CONTRACT"
$ENDP - read this the debt isn’t due til 2027 - $AZN which trades at $67 - has more debt:
WSB can cure cancer and make money at the same time
NVAX's short squeeze has begun. WSB, you know what to do
AstraZeneca looks bullish, Technical Analysis.
$GNPX Genprex INC FDA grants Fast Track status to Genprex’s drug for NSCLC treatment. Market Cap 120m. Competitors valuation above billions. Working with $AZN and $MRK. Potential buyout candidate.
$GNPX Genprex INC FDA grants Fast Track status to Genprex’s drug for NSCLC treatment. Market Cap 120m. Competitors valuation above billions. Working with $AZN and $MRK. Potential buyout candidate.
Difference technology between vaccine check the link
$EMO.V / $EMOTF Looking at a 10x+ in the next year DD
$ATNF - 180 Life Sciences announced top line data for the Early stage Dupuytren's disease phase 2b/3 will be presented no later than December 1 at the International Dupuytren Symposium in coop with the University of Oxford
$ATNF - 180 Life Sciences announced top line data for the Early stage Dupuytren's disease phase 2b/3 will be presented no later than December 1 at the International Dupuytren Symposium.
AUPH: Best treatment against Lupus nephritis, imminent buyout, still undervalued [Updated DD]
09/15 AMZN 3 bagger daytrade // Or why you always follow the volume
Enzolytics - The Gangs Gets Rich on a Penny Stock
SPY ITM C 6-8 Weeks out hasn't failed for me since June
The SEC should investigate the FDA about $SESN anyway i am holding
How did AZN end up in my Robinhood portfolio? I had never heard of it and it just ended up there!
The top 10 stocks on google search VS Mainstream media.
AUPH Buyout Target - Stock Has About a 250% Capital Gain Potential
The Bear Case for Summer: A crash in the next 4-8 weeks?
The Bear Case for Summer: A crash in the next 4-8 weeks?
Alexion (ALXN) / AstraZeneca (AZN) merger.
Could Tonix Pharmaceuticals ($TNXP) Be a Millionaire-Maker Stock?
Biotechs : Market completely missed the news of the week LONG $XBI $LABU
Moderna (MRNA) is the Tesla of the pharmaceutical and biotechnology world. Moderna to reach $600 by 2023.
S&P 500 Struggles for Direction, Hovers Near Record on Tech Strength
Can someone explain why AstraZeneca (AZN) hasn't tanked
Alexion ($ALXN): Opportunity to buy AstraZeneca ($AZN) at a discount (quick & dirty DD)
How da fuq is AZN still up?
Astrazeneca (nasdaq:AZN) may have relied on out of date info for drug trials | Currently down 3% w/ possibility to drop more [WSJ]
AstraZeneca vaccine - Norwegian scientists found connection to blood clots
Mentions
It isn't just about past performance - it is about what constitutes both indices. The top weights of SP500 are dominated by high growth companies - the ones that tend to move the indices up. The top weights of VXUS are majority mature companies. You have a company such as Nestle as top weight. Nestle is a great company and would have returned you a small ransom over decades of time. But they are no longer a company that can carry an index. Then you have some banks, big pharma etc - nice returns, but mature and not outsized returns. So my analysis is way beyond simple surface layer. AZN, SAP and NVS aren't outpacing NVDA MSFT AMZN GOOGL META BRKa/b NFLX. VXUS only has TSM as a top weight outsized return.
So anyway Mr. Chin comes in today to set up an account and I load him up with AZN, LID, and SLNT, a bangin port. Now I'm in a meeting with that bitch from HR for some reason, but at least she has some nice hangers amirite?
$AEP, $AZN, $Fast, $Orly… printing
im all in NVO and AZN. fml
Check that SPY chart. Should have bought calls instead of that AZN garbage
So AstraZeneca AZN calls? Historic deal, blah, blah, blah... Yes or no?
MSFT, AAPL GOOGL RR. AZN (I have a lot employee shares)
Yep, in for 300 AZN and 350 NVO
I bought some puts on both AZN and NVO. Are you still in or?
AstraZeneca’s $50B push into US manufacturing, kicked off back in July 2025, won’t straight-up kill off Trump’s 100% tariffs on imported drugs hitting Oct 1—but it basically gets AZN off the hook. The rules let companies skip the hit if they’re breaking ground on American plants, and with AZN already digging in Virginia plus ramps up in other states, they’re locking down that huge 40% chunk of US sales. Smart move turning tariff headaches into a win, especially with their UK headaches piling on.
AZN… British Pharma Company ya AZN is literally the single most valuable UK listed company, bar none. You aren’t sitting on a goldmine of undiscovered info here, brother.
Currently I own 300 of the AZN 10/10 70p which is about 6k. I’m planning to put down another 6k on NVO puts, probably 50/51p on the same date at approximately 11am when the premiums are lowest, depending on price movement.
Ran a little AI search last night when I was extremely crossfaded. Drug: Atorvastatin/Lipitor (PFE). US prescriptions: >115 million. Generic market share penetration: >90%. Drug: Lisinopril/Zestril (AZN). US prescriptions: >76 million. Generic market share penetration: 95% Drug: Levothyroxine/Synthroid (ABBV). US prescriptions: >80m. Generic market share penetration: ~60%
Drug: Atorvastatin/Lipitor (stock PFE). US prescriptions: >115 million. Generic market share penetration: >90%. Drug: Lisinopril/Zestril (AZN). US prescriptions: >76 million. Generic market share penetration: 95% Drug: Levothyroxine/Synthroid (ABBV). US prescriptions: >80m. Generic market share penetration: ~60% Read the fucking news. **BIG DICK MONEY INBOUND**
I am curious about $AZN and the big swiss pharma companies. I guess for $PFE it’s a good news?
AZN. Been a little weak lately but I'm in at like 65. Might get more a buck or two lower. Always has a consistent pipeline. Lots of names. And avoids the collapse of the dollar.
I did. We do exist. I am VERY happy with my EU and AZN mix. I am a year or 2 from retirement and felt dollar risks made a rotation of profits taken off MSTR and PLTR could go in VYMI, VXUS and also bought airbus and a few other French , Belgian and German cos. Only regret is Dasty, dassaullt software. That may be a loss harvest this year for taxes.
That's incredible! We need more days like this! While tech is being decimated... other sectors are attracting all the money! Berkshire, AZN, MRK, ... TJX, DOW, UL, ABBV, ...
$1000 into AZN and watch it ride
Bought in on AZN at 70.03 two days ago and is now up 6% in two days looking like it’s only up from here after they announced their plans to move to US
There will be no investment. It’s a press release designed for Trump to get his ‘good news’ 30 second clip. AZN can spin it out for 2 years and then drop because by then Trump will be likely engulfed in some other crisis of his own making.
The area of stupidity and just throwing shit against the wall has peaked. AZN is going to invest $50BN with only $5BN on hand? They gonna take $45B of financing? At what rate when they are competition with debt from the US Govmt and AI taking up even $ of debt available. What guarantee offtake are they going to get to back said debt? Dilute equity by $45B, to serve what markets? I'm sure existing shareholders will be thrilled.
July's been a good month. I mixed some high-risk biotechs with a few safer names and ended up with around a 21% gain overall. PHVS and COGT were the biggest movers for me, with strong gains after their catalysts. I also caught good momentum in RYTM and ELDN. A few micro-cap trades like ADIL and WINT gave quick spikes, which I sold into. The bigger AZN and GSK didn’t move much but helped balance things out. I’m taking profits and stepping back for the rest of July. Done with this month’s volatility and shifting focus to scouting August catalysts. Curious what others are watching and how you're thinking about the next round of PDUFA rally with delayed decision and CRLs
I think although Pfizer pays a nicer dividend, I think AZN has stronger pipeline and growth potential
To buy tomorrow UNH LONG TERM AZN short term (1 month) BRK B Stock 1/2 BUY plus CALL Contract (490) same day (short call) Hopefully , Call is profitable, wait until next dip to invest rest of 1/2 , then call again then TSLA PUT? 295? You’re welcome 😇
You realize the company announced a 1 billion dollar acquisition and partnerships with NVDA, AWS and AZN in the past three days? You have no idea why the ceo is selling but are posting FUD from a 6 month old account. Honestly, I hope you're selling puts because I definitely will.
Gold has been a wonderful play in an actually unexpected but exactly as expected way. We are in uncharted waters with the world order shifting to authoritarianism. Divestment in American stocks is happening. Dollar wobbling in new weird ways. Entering into GLD on last good gold dip has paid me back. Only a lil, I put most of my sold Murican stocks in EU and AZN div growth ETFs. I am afraid to take nice profits on my phys gold because obviously this is also a time you would be nuts to sell cheap into it gold.
So the squeeze occurs when the stock starts to bottom and then change direction. This forces the shorts to buy back stock. So if you want to lower your cost basis, let’s say if you own 100 shares of AZN you buy 100 more shares.
Scooped up some pharma at the start of the rebound. AZN & MRK still a good price even with the leap.
AZN. Healthcare stock based in UK. And it has had tons of good trial data lately.
Potentially yeah. Foreign company stocks might be positioned decently. Maybe something like AZN as well (astrazeneca)
AZN pumping is dumb. Gonna get destroyed by tariff
If you're not shorting these companies for April 2 lib day idk what to tell you AZN FCX GSK BHP RIO NVS WFG SCCO RDY
IBW provides a nice backstop for the company, still not priced in currently due to last MRE report not including gold - I’d say 800-1b market cap is where it should be on IBW alone - AZN will add a nice 1.5b in market cap rapidly once wrapped up on q3
I’ve been long on AZN for the past five years or so and have enjoyed the ride.
The pharma ones I have right now are ABT, AZN and LLY.
[$CTTH](https://x.com/search?q=%24CTTH&src=cashtag_click) great patent news for their drug delivery system (Micelle) and the Diabetic drugs. [$NVO](https://x.com/search?q=%24NVO&src=cashtag_click) [$LLY](https://x.com/search?q=%24LLY&src=cashtag_click) [$AZN](https://x.com/search?q=%24AZN&src=cashtag_click) [$AMGN](https://x.com/search?q=%24AMGN&src=cashtag_click) [$VKTX](https://x.com/search?q=%24VKTX&src=cashtag_click) [$GPCR](https://x.com/search?q=%24GPCR&src=cashtag_click)
So AAPL, VZ, AT$T, AZN, and PFE are tariff/recession proof; got it.
AZN Astrazeneca, don't know why or how. I made a lot recently and happy keeping it or buying more.
$BMRN - BioMarin Earnings, Undervalued & “Cash Cow” 🐮 BioMarin: - $BMRN Last quarter settled $495 million of convertible debt in cash • Last Quarter, Strong Demand Drove 54% Y/Y Revenue Growth for VOXZOGO. "Strong global demand for VOXZOGO led to over 3,900 infants and children receiving treatment” • Last Quarter, strong demand in VIMIZIM sales. Follow The Money - Elliot Investment Management Elliot has been part of some prominent deals: 2020 - AstraZeneca Buys Alexion $AZN 2022 - Elon Musk Twitter Deal $TSLA 2024 - Novo Holdings Buys Catalent - Same tactic being deployed on $BMRN #BioMarin BIOMARIN IS TRADING AT A DEEP DISCOUNT
$BMRN - BioMarin Earnings, Undervalued & “Cash Cow” 🐮 BioMarin: - $BMRN Last quarter settled $495 million of convertible debt in cash - Last Quarter, Strong Demand Drove 54% Y/Y Revenue Growth for VOXZOGO. "Strong global demand for VOXZOGO led to over 3,900 infants and children receiving treatment” - Last Quarter, strong demand in VIMIZIM sales. Follow The Money - Elliot Investment Management Elliot has been part of some prominent deals: 2020 - AstraZeneca Buys Alexion $AZN 2022 - Elon Musk Twitter Deal $TSLA 2024 - Novo Holdings Buys Catalent - Same tactic being deployed on $BMRN #BioMarin BIOMARIN IS TRADING AT A DEEP DISCOUNT
Nvo is my worst performer in terms of percentage. glad i only have $17 invested in it. I trimmed my lly around $945 and $830 and sold out hims, ozem, hrtz. i’m currently holding LLY, PFE, MRK, LNTH, AZN, NOVATIS, VERTEX AND NTRA HONESTLY SPEAKING, NONE OF THEM is rewarding except Natera. I chose healthcare to balance out my portfolio but they have been underperforming for last 3 to 4years. Don’t add new money to it. It would take very long to recover . if you have to buy some, buy LNTH, lly, pfe or vertex. Those 4 have signs of recover and they have good dividends. LNTH has for sure bottomed out and has been steadily recovering.. It’s one of my newly added positions. check it out..
AZN is a banger, I like BP & Equinor as well
I've been thinking about european stocks and I feel I will just end up adding to my europe ETF (MEUD). Top 10 Holdings are: NOVO; ASML, SAP, Nestle, Novartis, AZN, Roche, Shell, HSBC, Lvmh. Keep it safe and boring. Thoughts?
CSCO, PLTR, MRVL, CELH, AZN calls
Can’t make that call for you. Still a couple big gaps for AZN to fill so there may be meat left on the bone, but I have no problem taking 100% gains and moving on
I have some ITM AZN calls I bought a few weeks ago up 100%. Should I cash out and grab some MRNA calls? The IV is just much more attractive still on AZN than MRNA.
nov 5: buy [$AZN](https://x.com/search?q=%24AZN&src=cashtag_click) on weakness. buy [$VKTX](https://x.com/search?q=%24VKTX&src=cashtag_click). short [$MNPR](https://x.com/search?q=%24MNPR&src=cashtag_click). short [$SAVA](https://x.com/search?q=%24SAVA&src=cashtag_click).
Idk but I was watching some recorded podcasts over the weekend bc he discussed some of my own holdings and honestly overall gave me a different perspective on bio trading that you don’t really have to swing for blockbusters. Because of him I took up an AZN trade that crossed my mind but I wasn’t seriously entertaining. Now I’ll entertain these ideas more often
AZN has also separately had its own unique issues recently that folks have oversold on in my view.
A lot of pharmaceutical companies are doing badly right now including NVO and AZN.
More slightly OTM July calls on AZN
https://preview.redd.it/060ymb24dx1e1.jpeg?width=1242&format=pjpg&auto=webp&s=00937b18bd2c61cbe6ae2dea10e3455fe00300f0 Update: Looking good so far… the more I lose on the covered calls the happier I’ll be :) I also opened a separate $50k $AZN call options position that I might create a separate post for this weekend.
I must be holding the wrong European stocks. NVO, ROG, ASML and AZN are all red.
Holy shit $AZN 
>how do people approach the kind of ‘should have bought more’ remorse once a stock pops? I look at investing as more of a skill than random strokes of luck. Those are situations you hopefully learn from. Also, I bought one share of AZN back in the spring and all summer I watched it go up about $20 more than what I bought it for. I felt silly for just buying the one share because there was no point in selling it for an $20 appreciation. It's now down under what I initially bought it for. It's true that you can't time the market, but if you diversify enough, you'll get another chance to invest at lower price points with companies that fluctuate in valuation.
RDDT, VSCO, YETI, HSY, WEN, AZN,HBI, nuclear stocks full sweep
ok. is it time to add some? AZN has great product pipeline. But they are not that much into weight lost area.
> AZN Wondering the same, but I think it is the fear around the China Investigation of the CEO there.
MELI, FIX, ANET, AZN, KNSL, CNSWF (not a penny stock, just canadian)
I took my profit. Taking a more conservative approach with their replacements in my portfolio - added a half position in both AZN and NVS in early trading - AZN had dropped considerably so I hope the lower cost basis will be of benefit. Also VRTX. A bit less safe, but incredible potential.
AZN; NVS; ASML; SPOT; ETN are all in my portfolio. Because they are great companies with great potential. There are a lot of great European companies and there is no reason to ignore them completely. Diversifying across countries is not a bad thing, even if not necessary. Look for good companies in safe countries.
i did a backtest of a portfolio of COP, KO, AZN and D with 25% allocation each vs SP500 using https://testfol.io/ start date is 1993 and end date is today. SP500 portfolio beats the dividend portfolio in total return with a very slight volatility increase. > We don't have to every worry about the cost of senior living when she gets to that point your in-laws got rich because of consistently investing their money and having a pension from a state job. i think they would prob be just a lil richer with a sp500 portfolio. it is also much simpler compared to their 35 stock portfolio + mutual funds.
My late FIL built a massive stock portfolio over time specifically for this point in their lives, unfortunately he passed away in 2017. ETFs didn't exist when it was being built and when they did gain traction mutual funds were still the primary way of life. It has holdings in every sector and is less volatile than the S&P500 because on average it's beta is less than 1. Like, woman holds 458 shares of COP and they bought it in the late 80s. 351 shares of KO bought way back in the day. 262 shares of AZN bought way back in the day. 400 shares of D. These are just 4 examples of her 35 stock holdings, doesn't include her mutual funds or her state retirement. She owns her house outright and she doesn't touch anything that aren't her dividend payments which even then they sit in high earning accounts until she has to pay her electricity bill, etc. Growth is great, but so is her way of life. We don't have to every worry about the cost of senior living when she gets to that point, we can retire early when we combine our portfolios (which are equity growth and ETF heavy) with hers. I'm only 41 and I get to move to part time work in 5 years with just my portfolio. I grew up poor and was completely on my own (and still poor) once I was booted out at 18. I've built a great, stable life and I'm fine with the 7 figures we're already at, don't need to sacrifice that to maybe get to a higher 7 or even 8. Plus, my step kids won't have to worry about us the same way we don't worry about her.
Neither AZN (e.g. Japan or Hong Kong) nor European markets are open yet. Don't believe ~~everything~~ anything that you read here on WSB.
Not sure you should keep AZN. Add PYPL! It s way undervalued and currently breaking out as growth is back again. Consider PLTR but I would buy it slow on this one. Consider adding to NVDA as well
i bought on day of lockdown and picked AZN for the pharma sector 🤷🏼♂️
You bought AZN wanting to buy AMZN didn't you?
Calls on AZN, makers of the most popular schizo drugs. Up 26.7% YTD so far.
Here are some bets for the new world pandemic: NVO, MRNA, BVNRY, PFE, AZN. May the regarded odds be in your favor 
AZN is due for a 2 dollar day. 😤😤😤
AZN simply does not go down I think
My wish for tomorrow Nike - $90 CMG - $90 AZN - $90 PCOR - $90 VST - $90 Putin - turns 90 I lose 9 lbs
Looking to open a position in these... AZN, META, VNOM, LLY, NVO META, LLY, NVO I may wait a little though. I already have energy exposure with PR, but more doesn't hurt.
From article: **Conduit Pharmaceuticals** (NASDAQ:[**CDT**](https://investorplace.com/stock-quotes/cdt-stock-quote/)) stock is rocketing higher on Thursday after the clinical-stage specialty biopharmaceutical company announced [an exclusive license agreement](https://www.nasdaq.com/press-release/conduit-pharmaceuticals-enters-exclusive-license-agreement-astrazeneca-multiple) with **AstraZeneca** (NASDAQ:[**AZN**](https://investorplace.com/stock-quotes/azn-stock-quote/)). This has led to Conduit Pharmaceuticals obtaining exclusive rights for three product candidates in development at AstraZeneca. These include HK-4 glucokinase activators AZD1656 and AZD5658, as well as the myeloperoxidase inhibitor AZD5904. Development progress includes AZD1656 and AZD5904 completing Phase 1 clinical trials. Conduit Pharmaceuticals also notes that it intends to launch Phase 2 clinical trials for AZD1656 and AZD5658 this year to test their effectiveness as autoimmune disorder treatments. Conduit Pharmaceuticals CEO Dr. David Tapolczay said the following about the deal: >*“The potential of these assets to become important first-in-class medicines for patients is promising. Given the data from AstraZeneca’s clinical trials, we believe there is a strong rationale to initiate Phase II studies in multiple indications to progress to commercialization of these assets.”* [https://investorplace.com/2024/08/why-is-conduit-pharmaceuticals-cdt-stock-up-123-today/](https://investorplace.com/2024/08/why-is-conduit-pharmaceuticals-cdt-stock-up-123-today/)
could be a big week or two for my options 8/16 10c’s on UDMY 9/20 calls on ENVX, AZN, NVAX, HIMS, IRM 9/20 puts on CRWD 10/18 calls on ENVX 1/17/25 calls on SMMT, ASTS, DRS a couple of these positions are already pretty fuk, but just as many are up big
how did i end up long on so many biotechs like if NVAX finally gets a 100% efficacy covid vaccine, SMMT cures cancer and so does AZN, CRVO cures alzheimer's, and AKBA does...whatever i thought it was gonna do, i'm scrooge mcduck but if all that happens soon biden might re-enter the race lol
not unlike my wife, i'm long AZN
True ten bagger is AZN or CRVO on FDA approval plays this month
Cures for cancer? CALLS ON AZN
I had 1600 shares of PFE when it dropped like a rock. Now I have 2600 shares having lowered my basis when it was trading in the $25 range. But I like drug stocks and also hold ABBV, AZN, GSK, MRK, OGN, VTRS and a risky MRKR. I'm retired and like the steady income that drug stocks provide. i don't worry about the price fluctuations as I won't need to sell any of them. I get about $40k a year in dividends which is much more than I need to draw each year to live comfortably.
AZN and C taking off in the coming weeks... Remember where you heard it first!!!
This is the real DD. In addition to being the first new drug in 10 years, it's the first novel mechanism (PDE3 + PDE4 inhibitor) for COPD in 20 years. Global COPD rates are supposed to increase over the next 10 years, too. The nearest competitor in terms of mechanism is Daliresp, by AstraZeneca, which is a PDE4 inhibitor. Daliresp just went generic a couple years ago, so maybe AZN would be looking to pick up ensifentrine? Their finances look fine, plenty of runway to get sales going. I think I'm going to pick up some shares in this one.
AZN is undervalued. VRNA has huge short term upside. Do your DD.
If Whitney Westgate didn't pursue a career in porn... She would've gotten a BS in Marketing at a state school in NJ, and be a Pharma Sales Rep with AZN